<DOC>
	<DOCNO>NCT02117960</DOCNO>
	<brief_summary>The aim study comparison effect supplementation omega 3 placebo 8 week serum level BMP-4 , YKL40 , HSP70 , HSP27 patient cardiovascular disease .</brief_summary>
	<brief_title>Assessing Effects Omega-3 Supplementation Serum HSP27 , HSP70 , YKL40 , BMP-4 Levels Male Patient With CAD</brief_title>
	<detailed_description>The aim study comparison effect supplementation omega 3 placebo 8 week serum level BMP-4 , YKL40 , HSP70 , HSP27 patient cardiovascular disease . In randomized , double-blind clinical trial , placebo-controlled , single-center , phase two trial , 42men age 45-65 year Coronary Artery Disease enrol study Tehran Heart Center . After sign informed consent individual complete general information form , 24-hour food recall 3 day take participant begin end study , . Selected sample randomly classify 2 block group receive supplement placebo . The supplement group , receive 4 g/day omega 3 fatty acid 8 week placebo group also receive placebo ( contain 4 g edible paraffin ) ( similar term color , shape size ) . Patients recommend sustain diet medication dose ( ) study also advise maintain constant level physical activity . Blood sample collect 8-12 hour fast anthropometric variable , biochemical parameter physical activity trial measure .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>CHI3L1 protein , human</mesh_term>
	<criteria>CVD patient 45 65 year old , patient â‰¥ 50 % stenosis least one coronary angiogram demonstrate , body mass index range 18.5 35 , avoidance dietary supplement , vitamin herbal product least 3 month throughout intervention , willingness participation , people use omega 3 supplement last 3 month , chronic renal disease , GI disease , hepatobiliary disease , hematological disorder , hypo hyperthyroidism , Smokers</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>atherosclerotic</keyword>
	<keyword>BMP-4</keyword>
	<keyword>YKL40</keyword>
	<keyword>HSP70</keyword>
	<keyword>HSP27</keyword>
</DOC>